Literature DB >> 9309695

Defects in the mitochondrial energy metabolism outside the respiratory chain and the pyruvate dehydrogenase complex.

F J Trijbels1, W Ruitenbeek, M Huizing, U Wendel, J A Smeitink, R C Sengers.   

Abstract

Disturbances in substrate oxidations in muscle mitochondria from patients with a suspicion of a mitochondrial myopathy may arise from a deficiency of one or more of the complexes of the respiratory chain or of the pyruvate dehydrogenase complex. However, we found no clear-cut defect in a substantial part of such patients. In this report we discuss some of the other possibilities which could account for the disturbed substrate oxidation rates. Special attention will be paid to defects which are localized outside the respiratory chain, such as defects in post-respiratory chain enzymes, defects in transport mechanisms of the mitochondrial inner or outer membrane, deficiency of cofactors and deficiency of heat-shock protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9309695

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  14 in total

1.  Deficiency of the adenine nucleotide translocator in muscle of a patient with myopathy and lactic acidosis: a new mitochondrial defect.

Authors:  H D Bakker; H R Scholte; C Van den Bogert; W Ruitenbeek; J A Jeneson; R J Wanders; N G Abeling; B Dorland; R C Sengers; A H Van Gennip
Journal:  Pediatr Res       Date:  1993-04       Impact factor: 3.756

2.  Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate.

Authors:  R J Allen; S DiMauro; D L Coulter; A Papadimitriou; S P Rothenberg
Journal:  Ann Neurol       Date:  1983-06       Impact factor: 10.422

3.  Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus.

Authors:  S Zierz; G Jahns; F Jerusalem
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

4.  Mouse ubiquitous mitochondrial creatine kinase: gene organization and consequences from inactivation in mouse embryonic stem cells.

Authors:  K Steeghs; W Peters; M Brückwilder; H Croes; D Van Alewijk; B Wieringa
Journal:  DNA Cell Biol       Date:  1995-06       Impact factor: 3.311

5.  Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.

Authors:  S Ogasahara; A G Engel; D Frens; D Mack
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Altered kinetics of cytochrome c oxidase in a patient with severe mitochondrial encephalomyopathy.

Authors:  L G Nijtmans; P G Barth; C R Lincke; M J Van Galen; R Zwart; P Klement; P A Bolhuis; W Ruitenbeek; R J Wanders; C Van den Bogert
Journal:  Biochim Biophys Acta       Date:  1995-04-24

7.  An unusual metabolic myopathy: a malate-aspartate shuttle defect.

Authors:  D J Hayes; D J Taylor; P J Bore; D Hilton-Jones; D L Arnold; M V Squier; A E Gent; G K Radda
Journal:  J Neurol Sci       Date:  1987-12       Impact factor: 3.181

8.  Successful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine.

Authors:  P L Bernsen; F J Gabreëls; W Ruitenbeek; R C Sengers; A M Stadhouders; W O Renier
Journal:  Arch Neurol       Date:  1991-03

9.  Decreased synthesis and inefficient mitochondrial import of hsp60 in a patient with a mitochondrial encephalomyopathy.

Authors:  A Huckriede; E Agsteribbe
Journal:  Biochim Biophys Acta       Date:  1994-11-29

10.  A fatal, systemic mitochondrial disease with decreased mitochondrial enzyme activities, abnormal ultrastructure of the mitochondria and deficiency of heat shock protein 60.

Authors:  E Agsteribbe; A Huckriede; M Veenhuis; M H Ruiters; K E Niezen-Koning; O H Skjeldal; K Skullerud; R S Gupta; R Hallberg; O P van Diggelen
Journal:  Biochem Biophys Res Commun       Date:  1993-05-28       Impact factor: 3.575

View more
  1 in total

1.  FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction.

Authors:  Bimal N Desai; Benjamin R Myers; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.